Amyris Inc  

(Public, NASDAQ:AMRS)   Watch this stock  
Find more results for AMRS
2.29
0.00 (0.00%)
May 5 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 2.23 - 2.43
52 week 1.56 - 4.50
Open 2.31
Vol / Avg. 0.00/110,280.00
Mkt cap 181.42M
P/E     -
Div/yield     -
EPS -0.48
Shares 79.22M
Beta 2.28
Inst. own 49%
May 20, 2015
Amyris Inc Annual Shareholders Meeting - 5:00PM EDT - Add to calendar
May 5, 2015
Q1 2015 Amyris Inc Earnings Call
May 5, 2015
Q1 2015 Amyris Inc Earnings Release
Mar 5, 2015
Amyris Inc at Morgan Stanley MLP and Natural Gas Access Day
Feb 24, 2015
Q4 2014 Amyris Inc Earnings Call
Feb 24, 2015
Q4 2014 Amyris Inc Earnings Release
Feb 10, 2015
Amyris Inc at Stifel, Nicolaus Technology, Internet & Media Conference - Webcast
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin 525.71% 11.73%
Operating margin -236.90% -254.98%
EBITD margin - -185.00%
Return on average assets 102.89% 2.45%
Return on average equity - -
Employees 404 -
CDP Score - -

Address

5885 Hollis St Ste 100
EMERYVILLE, CA 94608-2405
United States - Map
+1-510-4500761 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Amyris, Inc. (Amyris) is focused on leveraging bioscience technology to develop and provide renewable compounds for a variety of markets. The Company applies its industrial bioscience technology platform to provide alternatives to select petroleum-sourced products used in consumer care, specialty chemical and transportation fuel markets. The Company's first commercialization efforts have been focused on a renewable hydrocarbon molecule called farnesene (Biofene), which forms the basis for a range of products including emollients, fragrance oils and diesel fuel. While the Company's platform is able to use a wide variety of feedstocks, the Company is initially focused on Brazilian sugarcane. The Company has entered into various contract manufacturing agreements to support its commercial production needs. The Company has two principal operating subsidiaries, Amyris Brasil Ltda. for production in Brazil, and Amyris Fuels, LLC.

Officers and directors

John G. Melo President, Chief Executive Officer, Director
Age: 49
Bio & Compensation  - Reuters
Raffi Asadorian Chief Financial Officer
Age: 45
Bio & Compensation  - Reuters
Joel Cherry Ph.D. President - Research and Development
Age: 54
Bio & Compensation  - Reuters
Karen D. Rohde Chief Human Resources Officer
Bio & Compensation  - Reuters
Jack Newman Ph.D. Chief Science Officer
Bio & Compensation  - Reuters
Nicholas Khadder General Counsel, Corporate Secretary
Age: 41
Bio & Compensation  - Reuters
Philippe Boisseau Director
Age: 53
Bio & Compensation  - Reuters
Patrick Y. Yang Ph.D. Director
Age: 67
Bio & Compensation  - Reuters
Abdullah Bin Khalifa Al Thani Independent Director
Age: 55
Bio & Compensation  - Reuters
Nam-Hai W. Chua Ph.D. Independent Director
Age: 70
Bio & Compensation  - Reuters